Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
University of Alabama at Birmingham · University of Alabama at Birmingham Hospital · +8 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,971
total citations
- FWCI
- 96.97
- Percentile
- 100%
- References
- 49
Citations per year
Authors
13Topics & keywords
Topics
Keywords
- Medicine
- Cetuximab
- Head and neck cancer
- Clinical endpoint
- Radiation therapy
- Rash
- Internal medicine
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.